Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Ph+ human ALL xenografts responds to FTY720 with an 80 % reduction in overall disease if treatment has been initiated early on
(2012) Radiat Oncol
InChiKey: ACOXQYLJOQAHST-ZDUSSCGKSA-N
Formula: C22H24N4O4
acts as a negative allosteric modulator of human P2X7 (pIC50 = 6
Palbociclib 1150 Ph+ human ALL xenografts respondsPalbociclib, also known as PD 0332991, is an orally available cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. Palbociclib selectively inhibits cyclin dependent kinase 4 (CDK4) and 6 (CDK6), thereby inhibiting retinoblastoma (Rb) protein phosphorylation early in the G1 phase leading to cell cycle arrest. This suppresses DNA replication and decreases tumor cell proliferation. CDK4 and 6 are serine threonine kinases that
US$ 18.99
US$ 19.99